Cargando…
The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort
INTRODUCTION: Hydroxychloroquine (HCQ) is an antimalarial drug that received worldwide news and media attention in the treatment of patients with coronavirus disease 2019 (COVID-19). This drug was used on the basis of its antimicrobial and antiviral properties despite lack of definite evidence of cl...
Autores principales: | Abdulrahman, Abdulkarim, AlSayed, Islam, AlMadhi, Marwa, AlArayed, Jumana, Mohammed, Sara Jaafar, Sharif, Aesha Khalid, Alansari, Khadija, AlAwadhi, Abdulla Ismael, AlQahtani, Manaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822757/ https://www.ncbi.nlm.nih.gov/pubmed/33484407 http://dx.doi.org/10.1007/s40121-021-00397-8 |
Ejemplares similares
-
The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes
por: Almadhi, Marwa Ali, et al.
Publicado: (2021) -
Is glucose-6-phosphatase dehydrogenase deficiency associated with severe outcomes in hospitalized COVID-19 patients?
por: Kumar, Nitya, et al.
Publicado: (2021) -
Quarantining arriving travelers in the era of COVID-19: balancing the risk and benefits a learning experience from Bahrain
por: Abdulrahman, Abdulkarim, et al.
Publicado: (2021) -
COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2
por: Kumar, Nitya, et al.
Publicado: (2022) -
Clinical and Epidemiological Characteristics of COVID-19 in a Multi-National Cohort in the Middle East
por: Mallah, Saad I., et al.
Publicado: (2021)